Beyond Hormones: Non-Hormonal Options for Menopause Symptoms

Not every woman with menopausal symptoms can take HRT, and not every woman who can, wants to. Some have a medical history — certain breast cancers, particular clotting conditions — that makes systemic hormones unsuitable or complicated. Others have weighed it up and simply prefer a different route. Either way, the question that follows is a reasonable one: if not hormones, then what?

The honest answer is that the non-hormonal menu is real but uneven. Some options are genuinely well-evidenced and underused. Some are reasonable and clearly described in the medical literature. And a large, lucrative category — the supplements marketed specifically at menopausal women — is mostly evidence-free, sold on hope and packaging. The useful thing is not to lump these together but to grade them honestly.

The best-evidenced option is one most people don't expect

Ask which non-hormonal treatment has the strongest evidence for hot flushes and night sweats, and the answer surprises people: cognitive behavioural therapy. Not as a way of "thinking your way out of" symptoms, but as a structured, well-studied intervention that changes how the body and mind respond to them.

CBT for menopause has decent trial support for reducing the impact and distress of vasomotor symptoms, and for improving sleep and mood during the transition. It does not necessarily reduce how often hot flushes occur, but it reliably reduces how much they bother people — and for many women, the bother is the actual problem. It carries no medication risks, helps with the sleep and mood symptoms that often travel alongside, and is recognised in UK guidance as a legitimate option rather than a fallback. Its main limitation is access — time, and often a trained therapist — a practical barrier rather than an evidential one.

The prescription options, described neutrally

Several prescription medicines not originally designed for the menopause have a recognised role in managing its symptoms, and they are worth understanding — not as recommendations, but as part of an honest map.

Certain antidepressants — specific SSRIs and SNRIs — can reduce the frequency and severity of hot flushes, independent of any effect on mood. This is a genuine pharmacological effect, not a sign the symptoms were "all in the mind"; these drugs influence the same temperature-regulating pathways involved in flushing. They can be a reasonable option, particularly where low mood or anxiety coexist, though they carry their own side-effects and interactions, and some interact with breast cancer medication — exactly the detail that makes this a prescriber's conversation rather than a self-selection.

A newer development is worth flagging because it is genuinely novel. A class of drugs targeting the brain's temperature-control pathway directly — the NK3 receptor antagonists, of which fezolinetant is the first to reach use — has emerged specifically for vasomotor symptoms. The mechanism is elegant: it acts on the very neurons that drive flushing, without using hormones at all, and early trial data show meaningful reductions in hot flushes. As with any newer medicine, the picture continues to mature, monitoring requirements apply, and it sits firmly within prescriber decision-making rather than anything a reader should pursue alone. It is mentioned here because an honest non-hormonal menu in 2026 has to include it — neutrally, neither hyped nor dismissed.

Other older medicines, used off-label for flushes in particular situations, also exist; the common thread is that all of them are prescription decisions weighed against an individual's history.

The category that mostly doesn't work

Now the uncomfortable part. Any pharmacy or health-food shop carries shelves of supplements aimed squarely at menopausal women — herbal blends, phytoestrogens, isoflavones, black cohosh, evening primrose oil, and an ever-changing cast of branded formulations promising relief.

The evidence for most of them, judged fairly, is weak. Where trials exist, results are often inconsistent and frequently no better than placebo — and placebo itself performs surprisingly well for hot flushes, which is exactly how an ineffective product acquires a glowing reputation. Black cohosh has been studied more than most and the evidence remains mixed at best, with safety questions of its own. Phytoestrogen and isoflavone supplements have not shown convincing, reliable benefit. "Natural" is not a synonym for "effective" or "safe": some of these products have genuine interactions, particularly with breast cancer treatment, and supplements are not regulated to the standard of medicines, so what is on the label is not guaranteed to be in the capsule.

None of this means a given woman didn't feel better on a supplement — many do, and the placebo response is real and not to be sneered at. It means the evidence does not support these products as treatments, and money spent on them is often money spent on hope. Worth knowing before the spending, not after.

The lifestyle measures, with realistic effect sizes

Lifestyle advice for the menopause ranges from genuinely useful to faintly insulting. Honestly graded: regular physical activity supports sleep, mood and long-term bone and heart health — which matters enormously across the menopausal years even if its direct effect on hot flushes is modest. Reducing flush triggers that many women notice — alcohol, caffeine, spicy food, hot environments — can help at the margins, individual to each person. Attention to sleep, stress and weight has real value during a demanding life stage.

What lifestyle measures will not usually do is abolish moderate-to-severe vasomotor symptoms on their own. Presenting them as a substitute for treatment in women with disruptive symptoms is one of the quieter unkindnesses of menopause advice — it implies suffering is a willpower problem. The fair framing is that these measures are worthwhile for their own sake and for long-term health, with a real but limited effect on the headline symptoms.

Practical takeaways

• CBT has the strongest evidence among non-hormonal options for reducing the impact of hot flushes, night sweats, sleep and mood symptoms — and is widely underused.
• Certain SSRIs/SNRIs and the newer NK3 antagonist fezolinetant can reduce vasomotor symptoms; both are prescriber decisions weighed against individual history.
• Most supplements marketed for menopause lack convincing evidence, are flattered by a strong placebo response, and can carry interactions.
• Lifestyle measures genuinely help sleep, mood and long-term health, with a modest direct effect on hot flushes — not a substitute for treatment in severe cases.
• "Non-hormonal" is a real and reasonable path, but the options vary enormously in how well they work.

What this doesn't mean

It doesn't mean HRT is the only legitimate treatment and everything else is second-rate — for many women, non-hormonal options are exactly the right choice, by necessity or preference. Nor does it mean supplements are universally harmful; most are simply ineffective rather than dangerous. The point is to spend effort and money where the evidence actually points.

When to seek medical advice

If you can't take HRT, or would rather not, it is worth a conversation about the evidence-based alternatives — particularly CBT and the prescription options, which a clinician can weigh against your history and any other medication, including breast cancer treatment. Tell whoever cares for you about any supplements you are taking, as some interact with prescribed medicines, and seek advice if symptoms are affecting your quality of life rather than assuming nothing can be done.

A closing thought

The non-hormonal conversation tends to get squeezed into the gap left by the HRT debate, as though it were a consolation prize. It isn't. For a great many women it is the right and sometimes the only sensible route — and it contains at least one genuinely effective, badly underused option in CBT, alongside real prescription choices and a newer class of drug built for exactly this purpose. The skill is in telling the well-evidenced from the well-marketed, and making the choice with someone who knows your full history.

Further reading and sources

• NICE NG23 — Menopause: diagnosis and management (including non-hormonal options and CBT)
• British Menopause Society — guidance on non-hormonal treatments for menopausal symptoms
• MHRA — safety and licensing information on medicines used for vasomotor symptoms
• Cochrane reviews — non-hormonal interventions and herbal therapies for hot flushes
• NHS — things you can do and treatments for menopause symptoms

Brand names are mentioned for identification only. The author has no commercial relationship with any manufacturer, and nothing here is an advertisement for, or recommendation to obtain, any medicine.